HAP Trading, LLC - BROOKLYN IMMUNOTHERAPEUTICS ownership

Back to all holdings Add to watchlist

BROOKLYN IMMUNOTHERAPEUTICS's ticker is BTX and the CUSIP is 114082100. A total of 53 filers reported holding BROOKLYN IMMUNOTHERAPEUTICS in Q3 2021. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.

Links
Filings
External links
Quarter-by-quarter ownership
HAP Trading, LLC ownership history of BROOKLYN IMMUNOTHERAPEUTICS
ValueSharesWeighting
Q4 2021$22,000
-74.7%
11,800
-62.5%
0.00%
-66.7%
Q3 2021$87,000
-10.3%
31,500
+23.0%
0.00%0.0%
Q2 2021$97,000–25,600–0.00%–
 Download
Other shareholders
BROOKLYN IMMUNOTHERAPEUTICS shareholders Q3 2021
NameSharesValueWeighting ↓
AJ WEALTH STRATEGIES, LLC 36,001$00.00%
View complete list of BROOKLYN IMMUNOTHERAPEUTICS shareholders